Minimally Invasive Liver Surgery for Metastases From Colorectal Cancer: Oncologic Outcome and Prognostic Factors

University Hospital, Gasthuisberg274 enrolled

Overview

Only few reports exist on long-term survival after minimally invasive liver surgery (MILS for colorectal liver metastases. No data are available assessing prognostic factors in the era of current modern treatment strategies. The aim of the current study is to analyze the long-term oncologic outcome after MILS for metastases from colorectal cancer and determine prognostic indicators.

Study Type

OBSERVATIONAL

Enrollment

274

Conditions

Long-term Oncologic Outcome of MILS in Patients With CRLM and Prognostic Indicators

Eligibility

Sex: ALLMin age: 18 YearsMax age: 90 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with CRLM * Surgery: resection and/or ablation * preoperative chemotherapy and/or biological agents are allowed * postoperative chemotherapy and/or biological agents are allowed * simultaneous colorectal resection is allowed Exclusion Criteria: * primary liver cancer * benign liver tumors * pregnancy

Locations (1)

University Hospitals Leuven KUL

Leuven, Vlaams-Brabant, Belgium

Outcomes

Primary Outcomes

overall survival

Time frame: 5 years

Secondary Outcomes

prognostic variables

Time frame: 5 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.